Exome Sequencing Identifies Population‐Specific Genetic Risk Factors for Progressive Supranuclear Palsy in Asia
Movement Disorders · 01.11.2026
DOI: 10.1002/mds.70595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 01.11.2026. Verfasst von Pin-Shiuan Chen und 41 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan. Die Arbeit nennt 60 Literaturangaben. Gefördert von: National Science and Technology Council, National Taiwan University Hospital, University of Malaya Parkinson's Disease and Movement Disorders Research Program.
Abstract (Originalsprache)
Background
Progressive supranuclear palsy (PSP) is a debilitating primary tauopathy. Although genome‐wide association studies have identified risk loci in European populations, the genetic architecture of PSP in Asia remains largely undefined.
Objectives
We aimed to identify population‐specific genetic risk factors in Asian patients with PSP.
Methods
We performed whole‐exome sequencing in 549 patients with PSP recruited across East and Southeast Asia. Variant frequencies were compared with 1492 whole‐genome–sequenced controls from the Taiwan Biobank. Novel variants were functionally evaluated using cellular and Drosophila models.
Results
Among 549 patients (mean age at onset 65.1 ± 7.4 years; 60.47% male), 29 (5.28%) carried heterozygous pathogenic or likely pathogenic variants, including 12 novel variants. Additionally, 127 patients (23.13%) harbored 144 rare variants of uncertain significance with minor allele frequency < 1%. Pathogenic variants were most frequently identified in ABCA7 (n = 6, 20.69%) and SMPD1 (n = 6, 20.69%), followed by BSN (n = 3, 10.34%) and MAPT (n = 2, 6.90%). Rare variant landscape analysis identified BSN as the most prominent contributor (38/173 total rare variants, 21.97%), followed by ABCA7 (13.29%), LRRK2 (10.40%), and MAPT (6.94%). Functional studies demonstrated that BSN variants enhance tau aggregation and neurodegeneration. Additionally, the common Asian LRRK2 variants were enriched in PSP, with p.G2385R significantly associated with PSP risk (odds ratio 2.75, 95% CI 1.77–4.32; P < 0.0001) and remained significant compared with Taiwan Biobank controls ( P = 0.02), whereas the association for p.R1628P was attenuated.
Conclusions
Our findings delineate an ancestry‐specific genetic architecture of PSP distinct from the MAPT ‐dominant pattern observed in European populations, providing mechanistic insights into disease biology. © 2026 International Parkinson and Movement Disorder Society.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Neurology, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan.
- Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan.
- Graduate Institute of Physiology, National Taiwan University, Taipei, Taiwan.
- Department of Pediatrics, National Taiwan University Children's Hospital, Taipei, Taiwan.
ORCID-Profile: Pin-Shiuan Chen, Rung-Juen Lin, Ni-Chung Lee, Jacob Shujui Hsu, Sung-Pin Fan, Cheng-Hsuan Li, Wei Luo, Xiaosheng Zheng, Han-Lin Chiang, Chun-Yu Chen, Yih-Ru Wu, Tsung-Lin Lee, Min-Yu Lan, Hsiu-Chen Chang, Shu-Yi Huang, Han-Joon Kim, Jee-Young Lee, Jung-Hwan Shin, Gerard Saranza, Taichi Nomura, Hiroaki Yaguchi, Wan-Ping Lee, Tzi Shin Toh, Yi Wen Tay, Azlina Ahmad-Annuar, Joshua Chin Ern Ooi, Yuen Kang Chia, Anis Nadhirah Khairul Anuar, Adeline Su Lyn Ng, Ai Huey Tan, Chih-Chiang Chan, Ichiro Yabe, Shen-Yang Lim, Chin-Hsien Lin
Förderung
- National Science and Technology Council
- National Taiwan University Hospital
- University of Malaya Parkinson's Disease and Movement Disorders Research Program
- the Science and Technology Program of Zhejiang Province
- Key Research and Development Program of Zhejiang Province
- Japan Society for the Promotion of Science (JSPS) KAKENHI Grants-in-Aid for Scientific Research
- Health and Labour Sciences Research Grant, administered by the Ministry of Health, Labour and Welfare, Tokyo, Japan
- Singapore's National Medical Research Council Clinician-Scientist Award
Zitieren
APA
Chen, P. S., Lin, R. J., Chen, H. Y., Cheng, L., Hung, M. Z., Lee, N. C., Hsu, J. S., Fan, S. P., Li, C. H., Tai, C. H., Luo, W., Zheng, X., Chiang, H. L., Chen, C. Y., Wu, Y. R., Lee, T. L., Chang, Y. Y., Lan, M. Y., Chang, H. C., …, & Lin, C. H. (2026). Exome Sequencing Identifies Population‐Specific Genetic Risk Factors for Progressive Supranuclear Palsy in Asia. Movement Disorders. https://doi.org/10.1002/mds.70595
Vancouver
Chen PS, Lin RJ, Chen HY, Cheng L, Hung MZ, Lee NC, et al. Exome Sequencing Identifies Population‐Specific Genetic Risk Factors for Progressive Supranuclear Palsy in Asia. Movement Disorders. 2026. doi:10.1002/mds.70595
BibTeX
@article{Chen2026,
author = {Chen, Pin-Shiuan and Lin, Rung-Juen and Chen, Huan-Yun and Cheng, Lie and Hung, Miao-Zi and Lee, Ni-Chung and Hsu, Jacob Shujui and Fan, Sung-Pin and Li, Cheng-Hsuan and Tai, Chun-Hwei and Luo, Wei and Zheng, Xiaosheng and Chiang, Han-Lin and Chen, Chun-Yu and Wu, Yih-Ru and Lee, Tsung-Lin and Chang, Yang-Yee and Lan, Min-Yu and Chang, Hsiu-Chen and Lu, Chin-Song and Huang, Shu-Yi and Kim, Han-Joon and Lee, Jee-Young and Shin, Jung-Hwan and Saranza, Gerard and Nomura, Taichi and Yaguchi, Hiroaki and Lee, Wan-Ping and Toh, Tzi Shin and Tay, Yi Wen and Ahmad-Annuar, Azlina and Ooi, Joshua Chin Ern and Chia, Yuen Kang and Anuar, Anis Nadhirah Khairul and Ng, Adeline Su Lyn and Tan, Yi Jayne and Tan, Ai Huey and Tan, Eng-King and Chan, Chih-Chiang and Yabe, Ichiro and Lim, Shen-Yang and Lin, Chin-Hsien},
title = {Exome Sequencing Identifies Population‐Specific Genetic Risk Factors for Progressive Supranuclear Palsy in Asia},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70595}
}
EUVIMED